Non-Obstructive Coronary Artery Disease due to COVID-19 Infection: St-Segment Elevation due to Endothelial Dysfunction
Non-Obstructive Coronary Artery Disease due to COVID-19 Infection
DOI:
https://doi.org/10.54393/pbmj.v6i06.895Keywords:
COVID infection, ST-elevation MI, Recanalized vessels, Non-obstructive Coronary ArteriesAbstract
The ongoing inflammatory process in COVID infection is reported to cause acute cardiac injury either due to direct cytotoxicity or oxidative stress injury to myocytes. Hypercoagulability and endothelial dysfunction are the two main events resulting in the transient thrombotic process. Objective: To assess the coronary artery occlusion in COVID infected patients presenting with ST-elevation myocardial injury. Methods: A descriptive case series study was conducted on 52 patients presenting with ST-elevation myocardial infarction along with COVID infection. Data was collected regarding demographic profile, Troponin levels, COVID PCR, changes in ECG, Echocardiographic findings and coronary arteries were assessed angiographically. Data were analyzed using SPSS software and various percentages were calculated. Results: Of all the 52 patients studied, 46 patients (88%) tested positive for COVID -19 on RT-PCR done via nasopharyngeal swab. Other 6 patients tested negative initially but they had findings on their CXR and HRCT suggestive of interstitial pneumonia. All the patients were in age group 30-60 years with 32 patients (62%) being males and 20 being females (38%). None of the patients previously had any history of angina or myocardial infarction. Inflammatory markers were raised in about 43 patients (82.7%). ECG showed ST segment elevation in anterior leads in 35 patients (67%) and in inferior leads in 9 patients (17%) and in lateral leads in 2 patients (3.8%). Qualitative Troponin I test was positive in all the patients, whereas, about 41 patients (78%) had Quantitative Troponin I test in high probability range. About 50 patients (96%) had Ejection Fraction greater than 45% and normal segmental wall motion analysis. The coronary arteries were reported to be normal or recanalized in 40 patients (76%) and mild-moderate disease in single or two vessels are present in rest of the 12 patients. None of the patients had shown culprit artery severe disease or clot burden on angiograms. Conclusions: Acute Cardiac injury in previously asymptomatic patients may be related to the pro-thrombotic state created by COVID-19 infection resulting in endothelial dysfunction and mimicking ST-elevation myocardial injury raising Troponin levels indicated by raised D-Dimers and CRP level. The auto-recanalization of the coronary arteries and normal echocardiographic findings, are good prognostic factors for the post cardiac injury rehabilitation.
References
Aasim MA, Mehmood MF, Gill A, Gaba WH. Uncommon Presentations of COVID-19. Annals of King Edward Medical University. 2021 Mar; 27(1): 139-45.
Vetta F, Vetta G, Marinaccio L. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a vicious circle. Journal of Cardiology and Cardiovascular Research. 2020 Sep; 1(2): 1-2. doi: 10.37191/Mapsci-JCCR-1(1)-010 DOI: https://doi.org/10.37191/Mapsci-JCCR-1(1)-010
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology. 2020 Jul; 5(7): 802-10. doi: 10.1001/jamacardio.2020.0950 DOI: https://doi.org/10.1001/jamacardio.2020.0950
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020 Jul; 5(7): 819-24. doi: 10.1001/jamacardio.2020.1096 DOI: https://doi.org/10.1001/jamacardio.2020.1096
Chen C, Yan JT, Zhou N, Zhao JP, Wang DW. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua xin xue guan bing za zhi. 2020: 567-71.
Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb; 368. doi: 10.1136/bmj.m606 DOI: https://doi.org/10.1136/bmj.m606
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The lancet. 2020 Feb; 395(10223): 470-3. doi: 10.1016/S0140-6736(20)30185-9 DOI: https://doi.org/10.1016/S0140-6736(20)30185-9
Bujak K, Kazik A, Wróbel M, Piegza J, Lekston A, Gąsior M. COVID-19 mimicking ST-elevation myocardial infarction. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2020 Jun; 16(2): 213-5. doi: 10.5114/aic.2020.95632 DOI: https://doi.org/10.5114/aic.2020.95632
Mustafa S, Zafar M, Agrawal N, Shahbaz A, Al-Khafaji N. COVID-19-associated myocarditis mimicking ST elevation myocardial infarction. Chest. 2020 Oct; 158(4): A572. doi: 10.1016/j.chest.2020.08.537 DOI: https://doi.org/10.1016/j.chest.2020.08.537
Mengal N, Saghir T, Rizvi SN, Khan N, Qamar N, Masood S, et al. Acute ST-elevation myocardial infarction before and during the COVID-19 pandemic: what is the clinically significant difference?. Cureus. 2020 Sep; 12 (9). doi: 10.7759/cureus.10523 DOI: https://doi.org/10.7759/cureus.10523
Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, et al. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation. 2020 Jun; 141(25): 2113-6. doi: 10.1161/CIRCULATIONAHA.120.047525 DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047525
Karbalai Saleh S, Oraii A, Soleimani A, Hadadi A, Shajari Z, Montazeri M, et al. The association between cardiac injury and outcomes in hospitalized patients with COVID-19. Internal and emergency medicine. 2020 Nov; 15: 1415-24. doi: 10.1007/s11739-020-02466-1 DOI: https://doi.org/10.1007/s11739-020-02466-1
Tahir F, Arif TB, Ahmed J, Malik F, Khalid M. Cardiac manifestations of coronavirus disease 2019 (COVID-19): a comprehensive review. Cureus. 2020 May; 12(5). doi: 10.7759/cureus.8021 DOI: https://doi.org/10.7759/cureus.8021
He XW, Lai JS, Cheng J, Wang MW, Liu YJ, Xiao ZC, et al. Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients. Zhonghua xin xue guan bing za zhi. 2020 Jun; 48(6): 456-60.
Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. European heart journal. 2020 May; 41(19): 1798-800. doi: 10.1093/eurheartj/ehaa231 DOI: https://doi.org/10.1093/eurheartj/ehaa231
Haussner W, DeRosa AP, Haussner D, Tran J, Torres-Lavoro J, Kamler J, et al. COVID-19 associated myocarditis: A systematic review. The American journal of emergency medicine. 2022 Jan; 51: 150-5. doi: 10.1016/j.ajem.2021.10.001 DOI: https://doi.org/10.1016/j.ajem.2021.10.001
Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et al. ST-segment elevation in patients with Covid-19—a case series. New England Journal of Medicine. 2020 Jun; 382(25): 2478-80. doi: 10.1056/NEJMc2009020 DOI: https://doi.org/10.1056/NEJMc2009020
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American college of cardiology. 2020 Jun; 75(23): 2950-73. doi: 10.1016/j.jacc.2020.04.031 DOI: https://doi.org/10.1016/j.jacc.2020.04.031
Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The lancet respiratory medicine. 2020 May; 8(5): 475-81. doi: 10.1016/S2213-2600(20)30079-5 DOI: https://doi.org/10.1016/S2213-2600(20)30079-5
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical research in cardiology. 2020 May; 109:531-8. doi: 10.1007/s00392-020-01626-9 DOI: https://doi.org/10.1007/s00392-020-01626-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com